Book contents
Section 4 - The Newborn
Published online by Cambridge University Press: 08 June 2018
Edited by
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Opioid-Use Disorders in PregnancyManagement Guidelines for Improving Outcomes, pp. 113 - 138Publisher: Cambridge University PressPrint publication year: 2018
References
References
Heroin Timeline. Heroin addiction. Available at: www.heroinaddiction.com/heroin_timeline.html. Accessed October 12, 2013.Google Scholar
Merry, J. A social history of heroin addiction. Br J Addict Alcohol Other Drugs 1975; 70(3):307–10.Google Scholar
Courtwright, D. Dark Paradise: Opiate Addiction in America Before 1940. Cambridge, MA: Harvard University Press; 1982.Google Scholar
Menninger-Lerchenthal, E. Die morphin kranheit der neugeborenen morphine stischer mutter Monatsschr. F Kinderh 1934; 60:182–93.Google Scholar
Happel, T. J. Morphinism in its relation to the sexual functions and appetite and its effects on the offspring of the users of the drug. Tr M Soc Tennessee 1892;162–79.Google Scholar
Earle, F. B. Maternal opium habit and infant mortality. Med Standard (Chicago) 1888; 3:2.Google Scholar
Perlstein, M. A. Congenital morphinism: A rare cause of convulsions in the newborn. J Am Med Assoc 1947;135(10):633.Google Scholar
Goodfriend, M. J., Shey, I. A., Klein, M. D. The effects of maternal narcotic addiction on the newborn. Am J Obstet Gynecol 1956; 71(1):29–36.CrossRefGoogle ScholarPubMed
Cobrinik, R. W., Hood, R. T. Jr, Chusid, E. The effect of maternal narcotic addiction on the newborn infant; review of literature and report of 22 cases. Pediatrics 1959; 24(2):288–304.CrossRefGoogle Scholar
National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA 1998; 280(22):1936–43.Google Scholar
Reddy, A. M., Harper, R. G., Stern, G. Observations on heroin and methadone withdrawal in the newborn. Pediatrics 1971; 48(3):353–8.CrossRefGoogle ScholarPubMed
Blinick, G., Jerez, E., Wallach, R. C. Methadone maintenance, pregnancy, and progeny. J Am Med Assoc 1973; 225:477–9.Google Scholar
Zelson, C., Rubio, E., Wasserman, E. Neonatal narcotic addiction: 10-year observation. Pediatrics 1971; 48:178.Google Scholar
Finnegan, L. P., Kron, R. E., Connoughton, J. F., Emich, J. P. A Scoring System for Evaluation and Treatment of the Neonatal Abstinence Syndrome: A New Clinical and Research Tool. In Morselli, P. I., Sereni, F., editors. Basic and Therapeutic Aspects of Perinatal Pharmacology. New York: Raven Press; 1975, pp. 139–53.Google Scholar
Lipsitz, P. J. A proposed narcotic withdrawal score for use with newborn infants. Clin Pediatr 1975; 14(6):592–4.Google Scholar
Auriacombe, M., Fatséas, M., Dubernet, J., Daulouède, J. P., Tignol, J. French field experience with buprenorphine. Am J Addict 2004; 13(suppl 1):S17–S28.Google Scholar
Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. Rockville, MD: Substance Abuse and Mental Health Administration; 2004. DHHS publication (SMA) 04-3939.Google Scholar
Marquet, P., Chevrel, J., Lavignasse, P., Merle, L., Lachâtre, G. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther 1997; 62(5):569–71.Google Scholar
Kayemba-Kay's, S., Laclyde, J. P. Buprenorphine withdrawal syndrome in newborns: A report of 13 cases. Addiction 2003; 98(11):1599–604.Google Scholar
Rao, R., Desai, N. S. Oxycontin and neonatal abstinence syndrome. J Perinatol. 2002; 22(4):324–5.CrossRefGoogle ScholarPubMed
McCarthy, J. J., Leamon, M. H., Willits, N. H., Salo, R. The effects of methadone dose regimen on neonatal abstinence syndrome. J Addict Med 2015; 9:105–10.Google Scholar
Kaltenbach, K., Jones, H. J. Neonatal abstinence syndrome: Presentation and treatment considerations. J Addict Med 2016; 10(4):217–33.CrossRefGoogle ScholarPubMed
Patrick, S. W., Schumacher, R. E., Bennyworth, B. D., et al. Neonatal abstinence syndrome and associated health care expenditures. JAMA 2012; 307(18):1934–40.Google Scholar
Ko, J. Y., Patrick, S. W., Tong, V. T., et al. Incidence of neonatal abstinence syndrome – 28 states, 1999–2013. MMWR 2016; 65(31):799–802.Google Scholar
Patrick, S. W., Davis, M. M., Lehmann, C. U., Cooper, W. O. Increasing incidence and geographical distribution of neonatal abstinence syndrome: United States 2009–2012. J Perinatol 2015; 35:650–5.Google Scholar
Vallapiano, N. L. G., Winkleman, T. N. A., Kozhimannil, K. B., Davis, M. M., Patrick, S. W. Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004–2013. JAMA Pediatr 2016; doi: 10.1001/jamapediatrics.2016.3750.Google Scholar
Finnegan, L. P., Kandall, S. R. Neonatal abstinence syndromes. In Aranda, J., Jaffe, S. J., editors. Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2005.Google Scholar
Gillogley, K. M., Evans, A. T., Hansen, R. L., Samuels, S. J., Batra, K. K. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol 1990; 163:1535–42.Google Scholar
Connaughton, J. F., Reeser, D., Schut, J., Finnegan, L. P. Perinatal addiction: Outcome and management. Am J Obstet Gynecol 1977; 129:679–86.CrossRefGoogle ScholarPubMed
Rorke, L. B., Reeser, D. S., Finnegan, L. P. Nervous system lesions in infants of opiate dependent mothers. Pediatr Res 1977; 11:565.Google Scholar
Holbrook, A. M., Baxter, J. K., Jones, H. E., et al. Infections and obstetrical outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine. Addiction 2012; 107(Suppl. 1):83–90.Google Scholar
Finnegan, L. P., Hagan, T., Kaltenbach, K. Opioid dependence: Scientific foundations for clinical practice, pregnancy and substance abuse: Perspectives and directions. Bull N Y Acad Med 1991; 67(3):223–9.Google Scholar
Hudak, M. L., Tan, R. C. Committee on drugs; committee on fetus and newborn American academy of pediatrics clinical report. Neonatal drug withdrawal. Pediatrics 2012; 129(2):e540–60.Google Scholar
Kaltenbach, K., Holbrook, A., Coyle, M., et al. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction 2012; 107(Suppl. 1):45–52.Google Scholar
Jansson, L. M., Diepietro, J. A., Elko, A., Velez, M. Infant autonomic functioning and neonatal abstinence. Drug Alcohol Depend 2010; 109:198–204.Google Scholar
Seligman, N. S., Salva, N., Hayes, E. J., et al. Predicting length of treatment for neonatal abstinence syndrome in methadone exposed infants. Am J Obstet Gynecol 2008; 396:e1–7.Google Scholar
Dryden, C., Young, D., Hepburn, M., Mactier, H. Maternal methadone use in pregnancy: Factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. Br J Obstet Gynecol 2009; 116(5):665–71.Google Scholar
Wachman, E. M., Newby, P. K., Vreeland, J., et al. The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence. J Addict Med 2011; 5(4):293–9.Google Scholar
Pritham, U. A., Paul, J. A., Hayes, M. J. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs 2012; 41(20):180–90.CrossRefGoogle ScholarPubMed
Choo, R. E., Huestis, M. A., Schroeder, J. R., Shin, A. S., Jones, H. E. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend 2004; 75:253–60.Google Scholar
Jones, H. E., Heil, S. H., Tuten, M., et al. Cigarette smoking in opioid dependent pregnant women: Neonatal and maternal outcomes. Drug Alcohol Depend 2013; 131(3):271–7.Google Scholar
Gibson, K. S., Starks, S., Kumar, D., Bailit, J. L. Relationship between gestational age and the severity of neonatal abstinence syndrome. Addiction 2017; 112(4):711–6.Google Scholar
Doberczak, T. M., Kandall, S. R., Wilets, I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 1991; 118:933–7.Google Scholar
Ruwanpathirana, R., Abedel-Latif, M. E., Burns, L., et al. Prematurity reduces the severity and need for treatment of neonatal abstinence syndrome. Acta Paediatr 2015; 104:e188–e94.Google Scholar
Dysart, K., Hsieh, H., Kaltenbach, K., Greenspan, J. S. Sequela of preterm versus term infants born to mothers on a methadone maintenance program: Differential course of neonatal abstinence syndrome. J Perinat Med 2007; 35:344–6.Google Scholar
Jones, H. E., Kaltenbach, K., Heil, S. H., et al., Neonatal abstinence syndrome after methadone or buprenorphine exposure. NEJM 2010; 363:2320–31.Google Scholar
Gaalema, D. E., Scott, T. L., Heil, S. H., et al. Differences in the profile of neonatal abstinence syndrome signs in methadone versus buprenorphine-exposed infants. Addiction 2012; 107(Suppl.):53–62.Google Scholar
Unger, A., Jagsch, R., Bawert, A., et al. Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates? Gender Medicine 2011; 8(6):355–64.Google Scholar
Holbrook, A., Kaltenbach, K. Gender and NAS: Does sex matter? Drug Alcohol Depend 2010; 112(1–2):156–9.Google Scholar
Wachman, E. M., Hayes, M. J., Brown, M. S., et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA 2013; 309(17):1821–7.Google Scholar
Wachman, E. M., Hayes, M. J., Lester, B. M., et al. Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. J Pediatr 2014; 165(3):472–8.CrossRefGoogle ScholarPubMed
Wachman, E. M., Hayes, M. J., Sherva, R., et al. Variations in opioid receptor genes in neonatal abstinence syndrome. Drug Alcohol Depend 2015; 155:253–9.Google Scholar
Cleary, B. J., Donelly, J., Strawbridge, J., et al. Methadone dose and neonatal abstinence syndrome – Systematic review and meta-analysis. Addiction 2010; 105:2071–84.Google Scholar
Jones, H. E., Jansson, L. M., O'Grady, K. E., Kaltenbach, K. The relationship between maternal methadone dose at delivery and neonatal outcomes: Methodological and design considerations. Neurotoxicol Teratol 2013; 39:110–5.CrossRefGoogle ScholarPubMed
Jones, H. E., Dengler, E., Garrison, A., et al. Neonatal outcomes and their relationship to buprenorphine dose during pregnancy. Drug Alcohol Depend 2014; 134:414–47.CrossRefGoogle ScholarPubMed
Brogly, S. B., Saia, K. A., Walley, A. Y., Du, H. M., Sebastian, P. Prenatal buprenorphine versus methadone exposure and neonatal abstinence syndrome: Systematic review and meta-analysis. Am J Epidemol 2014; 180:673–86.CrossRefGoogle ScholarPubMed
Jones, H. E., Finnegan, L. P., Kaltenbach, K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs 2012; 72(6):747–57.Google Scholar
Finnegan, L. P. Neonatal abstinence syndrome: Assessment and pharmacotherapy. In Rubaltelli, F. F., Granati, B., editors. Neonatal Therapy: An Update. New York: Elsevier; 1986, pp. 122–46.Google Scholar
Kron, R. E., Litt, M., Phoenix, M. D., Finnegan, L. P. Neonatal narcotic abstinence: Effects of pharmacotherapeutic agents and maternal drug usage on nutritive sucking behavior. J Pediatr 1976; 88:637–41.Google Scholar
Herzlinger, R. A., Kandall, S. R., Vaughan, H. G. Neonatal seizures associated with narcotic withdrawal. J Pediatr 1977; 91:638–41.Google Scholar
Kandall, S. R., Doberczak, T. M., Mauer, K. R., Strashun, R. H., Korts, D. C. Opiate v CNS depressant therapy in neonatal drug abstinence syndrome. Am J Dis Child 1983; 137:378–82.Google Scholar
Weinberger, S. M., Kandall, S. R., Doberczak, T. M., Thornton, J. C., Bernstein, J. Early weight-change patterns in neonatal abstinence. Am J Dis Child 1986; 140:829–32.Google Scholar
Finnegan, L. P. Pulmonary problems encountered by the infant of the drug-dependent mother. Clin Chest Med 1980; 1:311–25.Google Scholar
Finnegan, L. P. Influence of maternal drug dependence on the newborn. In Kacew, S., Lock, S., editors. Toxicologic and Pharmacologic Principles in Pediatrics. Washington, DC: Hemisphere; 1988.Google Scholar
Glass, L., Rajegowda, B. K., Kahn, E. J., Floyd, M. V. Effect of heroin on respiratory rate and acid–base status in the newborn. N Engl J Med 1972; 286:746–8.Google Scholar
Behrendt, H., Green, M. Nature of the sweating deficit of prematurely born neonates. N Engl J Med 1972; 286:1376–9.Google Scholar
NIDA Services Research Monograph Series. Drug Dependence in Pregnancy: Clinical Management of Mother and Child, Loretta Finnegan, Ed. ADAMHA, 1979.Google Scholar
Himmelsbach, C. K. The morphine abstinence syndrome, its nature and treatment. Ann Intern Med 1941; 15:829–39.Google Scholar
Ostrea, E. M., Chavez, C. J., Strauss, M. E. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr 1976; 88:642–5.Google Scholar
Green, M., Suffet, F. The neonatal narcotic withdrawal index: A device for the improvement of care in the abstinence syndrome. Am J Drug Alcohol Abuse 1981; 8(2):203–13.Google Scholar
Zahordony, W., Rom, C., Whitney, W., et al. The neonatal withdrawal inventory: A simplified score of newborn withdrawal. Dev Behav Pediatr 1998; 19(2):89–93.Google Scholar
Kraft, W. K., van den Anker, J. N. Pharmacologic management of the opioid neonatal abstinence syndrome. Pediatr Clin N Am 2012; 59:1147–65.Google Scholar
D'Apolito, K., Finnegan, L. Assessing Signs & Symptoms of Neonatal Abstinence Using the Finnegan Scoring Tool, An Inter-Observer Reliability Program, Neo Advances, 2010. www.neoadvances.comGoogle Scholar
Velez, M., Jansson, L. M. The opioid dependent mother and newborn dyad: Non-pharmacological care. J Addict Med 2008; 2(3):133–20.Google Scholar
Wachman, E. M., Newby, P. K., Vreeland, J., et al. The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence. J Addict Med 2011; 5(4):293–9.Google Scholar
Welle-Strand, G. K., Skurtveit, S., Jansson, L. M. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatr 2014; 165(3):440–6.Google Scholar
Short, V., Gannon, M., Abatemarco, D. J. Association between breastfeeding and length of stay among infants diagnosed with NAS: A population based study of in-hospital births. Breastfeed 2016; 11:343–9.Google Scholar
Abrahams, R. R., Key, S. A., Payne, S., et al. Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Can Fam Physicians 2007; 53(10):1722–30.Google Scholar
Newman, A., Davies, G. A., Dow, K., et al. Rooming-in care for infants of opioid dependent mothers: Implementation and evaluation at a tertiary care hospital. Can Fam Physicians 2012; 61(12):555–61.Google Scholar
Saiki, T., Lee, S., Hannam, S. Neonatal abstinence syndrome – Postnatal ward versus neonatal unit management. Eur J Pediatr 2010; 169:95–8.Google Scholar
Hunseler, C., Bruckle, M., Roth, B., Kribs, A. Neonatal opiate withdrawal and rooming-in: A retrospective analysis of a single study experiment. Klin Pediatri 2013; 225(5):247–51.Google Scholar
Holmes, A. V., Atwood, E. C., Whalen, B., et al. Rooming-in to treat neonatal abstinence syndrome: Improved family centered care and lower cost. Pediatrics, 2016; doi: 10.1542/peds.2015-2929.Google Scholar
Hall, E. S., Wexelblatt, S. L., Crowley, M., et al. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics, 2014; 14(2):e527–e34.Google Scholar
Asti, L., Magers, J. S., Keels, E., Wispe, J., McClead, R. E. A quality improvement project to reduce length of stay for neonatal abstinence syndrome. Pediatrics, 2015; 135(6):e1494–1500.Google Scholar
Hall, E. S., Wexelblatt, S. L., Crowley, M. Implementation of a neonatal abstinence syndrome scoring weaning protocol. Pediatrics, 2015; 136(4):e803–10.CrossRefGoogle Scholar
Osborn, D. A., Jeffery, H. E., Cole, M. J. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2010; (10): Art. No. CD002053; doi: 10.1002/14651858.CD002053.pub3.Google Scholar
Jackson, L., Ting, A., McKay, S., Galea, P., Skeoch, C. A randomized controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child 2004; 89(4 Special Issue):F300–4.Google Scholar
Finnegan, L. P., Kaltenbach, K. Neonatal abstinence syndrome. In Hoekelman, R. A., Friedman, S. B., Nelson, N., editors. Primary Pediatric Care. 2nd ed. St. Louis, MO: CV Mosby; 1992, pp. 1367–8.Google Scholar
Kandall, S. R. Treatment strategies for drug-exposed neonates. Clin Perinatol 1999; 26:231–43.Google Scholar
Kraft, W. K., Gibson, E., Dysart, K., et al. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: A randomized trial. Pediatrics 2008; 122(3):e601–7.Google Scholar
Kraft, W. K., Dysart, K., Greenspan, J. S. Revised dose schema of sublingual buprenorphine in the treatment of neonatal opioid syndrome. Addiction 2011; 106(3):574–80.Google Scholar
Kraft, W. K., Adeniyi-Jones, S. C., Chervoneva, I., et al. Buprenorphine for the treatment of the neonatal abstinence syndrome. N Engl J Med 2017; doi: 10.1065/NEJMoa1614835.Google Scholar
Sarkar, S., Dunn, S. M. Management of neonatal abstinence syndrome in neonatal intensive care units: A national survey. J Perinatol 2006;26(1):15–7.Google Scholar
O'Grady, M. J., Hopewell, J., White, M. J. Management of neonatal abstinence syndrome: A national survey and review of practice. Arch Dis Child Fetal Neonatal Ed 2009; 94(4):F249–52.Google Scholar
Weiner, S. M., Finnegan, L. P. Drug withdrawal in the neonate. In Carter, B., Gardner, S., editors. Handbook of Neonatal Intensive Care, 8th ed. St. Louis, MO: Mosby-Year Book Inc; 2016.Google Scholar
Bio, L. L., Siu, A., Poon, C. Y. Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol 2011; 31(11):692–701.Google Scholar
Osborn, D. A., Jeffery, H. E., Cole, M. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2002; (3):CD002053.Google Scholar
Osborn, D. A., Jeffery, H. E., Cole, M. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2005; (3):CD002059.Google ScholarPubMed
Kocherlakota, P., Neonatal abstinence syndrome, Pediatrics 2014 Aug; 134(2):e547–61.CrossRefGoogle ScholarPubMed
North Carolina Pregnancy & Opioids Exposure Project. www.ncpoep.org/guidance-document/neonatal-abstinence-syndrome-overview/appendix-a-neonatal-abstinence-syndrome-nas-scoring-explanation/Google Scholar
Ebner, N., Rohrmeister, K., Winklbaur, B., et al. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2007;87(2–3):131–8.Google Scholar
Leikin, J. B., Mackendrick, W. P., Maloney, G. E., et al. Use of clonidine in the prevention and management of neonatal abstinence syndrome. Clin Toxicol (Phila) 2009; 47(6):551–5.Google Scholar
Esmaeili, A., Keinhorst, A. K., Scuster, T., et al. Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate. Acta Paediatr 2010; 99(2):209–14.Google Scholar
Bada, H. S., Sithisarn, T., Gibson, J., et al. Morphine versus clonidine for neonatal abstinence syndrome. Pediatrics 2015 Feb; 135(2):e383–91.Google Scholar
Kaltenbach, K., Finnegan, L. P. Neonatal abstinence: Pharmacotherapy and developmental outcome. Neurobehav Toxicol Teratol 1986; 8:353–5.Google Scholar
Behnke, M., Smith, V. C. Prenatal substance abuse: Short and long term effects of the exposed fetus. Pediatrics 2013; 131:e1009–e24.Google Scholar
References
Mack, K., Jones, C., Paulozzi, L. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women – United States, 1999–2010. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6226a3.htm.Google Scholar
Patrick, S. W., Davis, M. M., Lehmann, C. U., Cooper, W. O. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Journal of Perinatology: Official Journal of the California Perinatal Association. 2015; 35(8):650–5. doi:10.1038/jp.2015.36.Google Scholar
Cirillo, C., Francis, K. Does breast milk affect neonatal abstinence syndrome severity, the need for pharmacologic therapy, and length of stay for infants of mothers on opioid maintenance therapy during pregnancy? Advances in Neonatal Care. 2016; 16(5):369–78.Google Scholar
Jansson, L. M., Velez, M. L., Harrow, C. Methadone maintenance and lactation: a review of the literature and current management guidelines. Journal of Human Lactation. 2004; 20(1):62–71.Google Scholar
Kim, P., Feldman, R., Mayes, L. C., et al. Breastfeeding, brain activation to own infant cry, and maternal sensitivity. Journal of Child Psychology and Psychiatry. 2011; 52(8):907–15.Google Scholar
Demirci, J. R., Bogen, D. L., Klionsky, Y. Breast-feeding and methadone therapy: the maternal experience. Substance Abuse. 2014; 4:1–6.Google Scholar
Wachman, E. M., Byun, J., Philipp, B. L. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeeding Medicine. 2010; 5(4). doi: 10.1089=bfm.2009.0079.Google Scholar
CDC. Breastfeeding Report Card: United States, 2014. www.cdc.gov/breastfeeding/pdf/2014breastfeedingreportcard.pdfGoogle Scholar
Rutherford, H., Williams, S. K., Moy, S., Mayes, L. C., Johns, J. M. Disruption of maternal parenting circuitry by addictive process: rewiring of reward and stress systems. Frontiers in Psychiatry. 2011 Jul 6; 2:37. doi: 10.3389/fpsyt.2011.00037.Google Scholar
DiSantis, K. I., Collins, B. N., McCoy, A. C. Associations among breastfeeding, smoking relapse, and prenatal factors in a brief postpartum smoking intervention. Acta obstetricia et gynecologica Scandinavica. 2010; 89(4):582–6.Google Scholar
Frank, D. A., Bauchner, H., Zuckerman, B. S., Fried, L. Cocaine and marijuana use during pregnancy by women intending and not intending to breastfeed, Research and Professional Briefs. Journal of the American Dietetic Association. 1992; 2(92):215–17.Google Scholar
Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The NSDUH Report: Substance Use Among Women During Pregnancy and Following Childbirth. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2009. www.openminds.com/wp-content/uploads/indres/052109nsduhpregnancysubabuse.pdf. Accessed March 15, 2017.Google Scholar
Cone, E., Bigelow, G. E., Herrmann, E. S., et al. Nonsmoker exposure to secondhand cannabis smoke. III. Oral fluid and blood drug concentrations and corresponding subjective effects. Journal of Analytical Toxicology. 2015; 1–13.Google Scholar
Winecker, R. E., Goldberger, B. A., Tebbetz, I. R., et al. Detection of cocaine and its metabolites in breast milk. Journal of Forensic Sciences. 2001; 46(5):1221–3.Google Scholar
Chasnoff, I. J., Lewis, D. E., Squires, L. Cocaine intoxication in a breast-fed infant. Pediatrics. 1987; 80:836–8.Google Scholar
Chomchai, C., Chomchai, S., Kitsommart, R. Transfer of methamphetamine (MA) into breast milk and urine of postpartum women who smoke MA tablets during pregnancy: implications for initiation of breastfeeding. Journal of Human Lactation. 2016; 32(2):333–9.Google Scholar
Bartu, A., Dusci, L. J., Ilett, K. F. Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine. British Journal of Clinical Pharmacology. 2009; 67(4):455–9.Google Scholar
Ariagno, R., Karch, S. B., Middleberg, R., Stephens, B. G., Valdes-Dapena, M. Methamphetamine ingestion by a breast-feeding mother and her infant's death: People v Henderson. JAMA. 1995; 274:215.Google Scholar
Kaufman, K. R., Petrucha, R. A., Pitts, F. N. Jr, Weekes, M. E. PCP in amniotic fluid and breast milk: case report. Journal of Clinical Psychiatry. 1983 Jul; 44(7):269–70.Google Scholar
Mennella, J. Alcohol's effect on lactation, 2012. http://pubs.niaaa.nih.gov/publications/arh25-3/230-234.htm. Accessed March 15, 2017.Google Scholar
Giglia, R., Binns, C. Alcohol and lactation: a systematic review. Nutrition & Dietetics. 2006; 63:103–16.Google Scholar
Kelly, L. E., Poon, S., Madadi, P., Koren, G. Neonatal benzodiazepines exposure during breastfeeding. The Journal of Pediatrics. 2012; 161:448–51.Google Scholar
Rubin, E. T., Lee, A., Ito, S. When breastfeeding mothers need CNS-acting drugs. Canadian Journal of Clinical Pharmacology. 2004; 11:257–66.Google Scholar
Lam, J., Kelly, L., Ciszkowski, C., et al. Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. Journal of Pediatrics. 2012; 160:33–7.Google Scholar
Hendrickson, R. G., McKeown, N. J. Is maternal opioid use hazardous to breast-fed infants? Clinical Toxicology (Philadelphia, PA). 2012; 50(1):1–14.Google Scholar
United States Food and Drug Administration. www.fda.gov/Drugs/DrugSafety/ucm118113.htm. Accessed April 26, 2017.Google Scholar
ElSohly, M. A. Potency Monitoring Program Quarterly Report No. 123 – Reporting Period: 09/16/2013–12/15/2013. Oxford: University of Mississippi, National Center for Natural Products Research, 2014.Google Scholar
Perez-Reyes, M., Wall, M. E. Presence of D9-tetrahydrocannabinol in human milk. The New England Journal of Medicine. 1982; 307:819–20.Google Scholar
Fernando-Ruiz, J., Gomez, M., Hernandez, M., et al. Cannabinoids and gene expression during brain development. Neurotoxicity Research. 2004; 6:389–401.Google Scholar
Liston, J. Breastfeeding and the use of recreational drugs, alcohol, caffeine, nicotine and marijuana. Breastfeeding Review. 1998; 6:27–30.Google Scholar
Garry, A., Rigourd, V., Amirouche, A., et al. Cannabis and breastfeeding. Journal of Toxicology. 2009; 596149 Epub 2009 Apr 29.Google Scholar
Kozhimannil, K. B., Graves, A. J., Levy, R., Patrick, S. W. Predictors of prescription opioid abuse among pregnant US women. Women's Health Issues. 2017; 27(3):308–15. doi: 10.1016/j.whi.2017.03.001.Google Scholar
Jansson, L. M., Choo, R., Velez, M. L., et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics. 2008; 121(1):106–14.Google Scholar
Jansson, L. M., Spencer, N., McConnell, K., et al. Maternal buprenorphine maintenance and lactation. Journal of Human Lactation. 2016; 32(4):675–81.Google Scholar
Velez, M. L., Montoya, I. D., Jansson, L. M., et al. Exposure to violence among substance-dependent pregnant women and their children. Journal of Substance Abuse Treatment. 2006; 30:31–8.Google Scholar
Kendall-Tackett, K. Breastfeeding and the sexual abuse survivor. Journal of Human Lactation. 1998 Jun; 14(2):125–30.Google Scholar
Kendall-Tackett, K., Cong, Z., Hale, T. W. Depression, sleep quality, and maternal well-being in postpartum women with a history of sexual assault: a comparison of breastfeeding, mixed-feeding, and formula-feeding mothers. Breastfeeding Medicine. 2013 Feb; 8(1):16–22.Google Scholar
Als, H. Toward a synactive theory of development: Promise for the assessment and support of infant individuality. Infant Mental Health Journal. 1982; 3(4):229–43.Google Scholar
Jansson, L. M., Velez, M. Neonatal abstinence syndrome. Current Opinion in Pediatrics. 2012; 24(2):252–8.Google Scholar
Derauf, C., Katz, A. R., Easa, D. Agreement between maternal self-reported ethanol intake and tobacco use during pregnancy and meconium assays for fatty acid ethyl esters and cotinine. American Journal of Epidemiology. 2003; 158(7):705–9.Google Scholar
Wright, T. E., Milam, K. A., Rougee, L., Tanaka, M. D., Collier, A. C. Agreement of umbilical cord drug and cotinine levels with maternal self-report of drug use and smoking during pregnancy. Journal of Perinatology: Official Journal of the California Perinatal Association. 2011; 31(5):324–9.Google Scholar
Reece-Stremtan, S., Marinelli, K. A. Academy of breastfeeding medicine. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorders, revised. Breastfeeding Medicine. 2015; 10:135–41.Google Scholar
Section on Breastfeeding, American Academy of Pediatrics. Breastfeeding and the use of human milk. Pediatrics. 2012; 129(3):e827–41.Google Scholar
Committee on Health Care for Underserved Women and the American Society of Addiction Medicine. Opioid Abuse, Dependence, and Addiction in Pregnancy. ACOG Committee Opinion No. 524. 2012; 1–7.Google Scholar
Bergeria, C. L., Heil, S. H. Surveying lactation professionals regarding marijuana use and breastfeeding. Breastfeeding Medicine. 2015; 10(7):377–80.Google Scholar
E Stanton, Esq. Vermont Oxford Network, 2014. Holmes, A. V., Atwood, E. C., Whalen, B., et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics. 2016 Jun;137(6). pii:e20152929. doi: 10.1542/peds.2015-2929.Google Scholar
Patrick, S. W., Schumacher, R. E., Horbar, J. D., et al. Improving care for neonatal abstinence syndrome. Pediatrics. 2016; 137(5). doi: 10.1542/peds.2015-3835.Google Scholar
Holmes, A. V., Atwood, E. C., Whalen, B., et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics. 2016; 137(6). pii:e20152929.Google Scholar
Jansson, L. M., Velez, M. Lactation and the substance-exposed mother–infant dyad. The Journal of Perinatal & Neonatal Nursing 2015 Oct–Dec; 29(4):277–86.Google Scholar